News

COVID-19 Vaccine

Reuters | Equities.com |

The World Health Organization (WHO) on Monday listed AstraZeneca and Oxford University’s COVID-19 vaccine for emergency use, widening access to the relatively inexpensive shot in the developing world.

“We now have all the pieces in place for the rapid distribution of vaccines. But we still need to scale up production,” Tedros Adhanom Ghebreyesus, WHO Director-General, told a news briefing.


Kimberly Redmond | Equities.com |

Individuals who have received the full course of COVID-19 vaccines can skip the standard 14-day quarantine if they are exposed to the virus, according to newly-revised guidance from the U.S. Centers for Disease Control and Prevention.

Quarantining is not necessary for fully vaccinated people who have received their last vaccine dose within three months – as long as they do not develop any symptoms, the CDC said.


Reuters | Equities.com |

When the U.S. government began shipping COVID-19 vaccines in December, state health providers could not administer shots fast enough to keep pace with deliveries and millions of doses sat waiting for arms.

Two months later, the situation has reversed. Supply constraints are slowing ambitious vaccination programs, as massive sites capable of putting shots into thousands of arms daily in states including New York, California, Florida and Texas, as well as hospitals and pharmacies, beg for more doses.


Kimberly Redmond | Equities.com |

The European Commission revised its outlook for the eurozone’s economic recovery, projecting a lower growth rate in 2021 as a second wave of the COVID-19 pandemic has triggered another round of lockdowns.

But, in its winter interim econonic forecast released Thursday, the Brussels-based institution revised projections for next year, saying 2022’s growth will be stronger than initially expected due to more widespread vaccination rollouts and loosened social restrict...


AP News | Equities.com |

About 1 in 3 Americans say they definitely or probably won’t get the COVID-19 vaccine, according to a new poll that some experts say is discouraging news if the U.S. hopes to achieve herd immunity and vanquish the outbreak.

The poll from The Associated Press-NORC Center for Public Affairs Research found that while 67% of Americans plan to get vaccinated or have already done so, 15% are certain they won’t and 17% say probably not. Many expressed doubts about the vaccine’s safety and effectiveness.


AP News | Equities.com |

South Africa will give the unapproved Johnson & Johnson vaccine to its front-line health workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant there, the health minister said Wednesday.

Zweli Mkhize said South Africa has scrapped plans to use the Oxford-AstraZeneca vaccine because it “does not prevent mild to moderate disease” of the variant.


AP News | Equities.com |

Hing Yiu Chung lives in a racially diverse San Francisco neighborhood hit hard by the coronavirus pandemic. While vaccines have been difficult to come by, the 69-year-old got one by showing proof she lives where she does.

She had to wait in line for two hours with other seniors, some who were disabled or leaning on canes, for a chance at a couple hundred shots available each day through a local public health clinic in the Bayview neighborhood.

“Fortunately, it wasn’t a cold or rainy day, otherwise it would have been harder,” she said in Chinese.


Kimberly Redmond | Equities.com |

The U.S. Food and Drug Administration is developing a quick review process of COVID-19 booster shots, tests and drugs in an effort to respond to new variants of the virus.

On Thursday, the agency’s acting commissioner, Dr. Janet Woodcock, said the agency is creating guidelines to address tweaks to authorized treatments and vaccines as needed, as well as looking for areas of regulatory flexibility.


Reuters | Equities.com |

Johnson & Johnson (NYSE: JNJ) said on Thursday it has asked U.S. health regulators to authorize its single-dose COVID-19 vaccine for emergency use, and it will apply to European authorities in coming weeks.

The drugmaker’s application to the U.S. Food and Drug Administration (FDA) follows its Jan. 29 report in which it said the vaccine had a 66% rate of preventing infections in its large global trial.


Kimberly Redmond | Equities.com |

McDonald’s Corp (NYSE: MCD) announced plans to give corporate and company-store workers up to four hours of paid time off to get vaccinated against COVID-19.

On Tuesday, the fast-food giant said it will not require employees to receive the vaccination but will connect them to third-party experts who can answer questions about the shots.